Regional partnerships Strategic distribution agreements across Europe and Japan indicate strong partner networks; leverage these relationships to propose co-marketed sales and bundled solutions that expand reach in targeted regions.

Integrated workflows Vela combines Real-Time PCR and Next-Generation Sequencing in a scalable, open-channel platform; position as a unified solution for labs seeking to streamline infectious disease and oncologic testing with flexible, cost-reducing instruments.

NGS panel expansion The OncoKey 525 Plus and SL 60 panels enable high-throughput cancer biomarker profiling; target oncology labs and reference centers with scalable panels that fit mid-to-large sequencing workflows.

Global reach Headquartered in Singapore with international distribution partners; identify opportunities in EMEA and APAC through joint promotions, regional trials, and localized support to accelerate adoption.

Strategic growth signals Recent collaborations and product launches around Sentosa instruments and RUO workflows suggest a momentum-focused sales approach; align offerings with labs upgrading to high-throughput, end-to-end diagnostic platforms.